Objective: Ethiopia has made meaningful headway in improving access to HIV care and treatment but client attrition remains a daunting challenge. The objective of this study was to describe the major reasons of patient attrition from treatment at hospital and health center levels in Oromia region of Ethiopia. Methods: This qualitatively designed study was based on semistructured interview with antiretroviral therapy (ART) service providers and focus group discussions with ART clients. The participants were recruited purposively to obtain robust and programmatically important information on in retention HIV care and treatment. Findings: The analysis identified four major themes: antiretroviral (ARV) medications as ''long-term life support,'' free ART as ''expensive,'' regular follow up as ''devotion to a life-long crisis management,'' and expansion of free ART as ''sharing the new hope,'' Conclusion: The finding clearly illustrated that while financial constraints and some sociocultural factors impede adherence, disclosure, community support, and decentralization of ART to primary health care units enhance retention in care and treatment.
Background
HIV/AIDS has remained to be the world's leading killer infectious disease. At the end of 2008, an estimated 33.4 million people worldwide were living with HIV and about 2 million people died of AIDS. Moreover, about 2.7 million people became newly infected with the virus in that same year which puts the pace of epidemic ahead of HIV repose. 1 Even though the incidence of infection with HIV is still high, reduction in AIDS incidence and mortality have been reported during the last few years. This was associated with the availability of the antiretroviral therapy (ART). 2 With the introduction of antiretroviral (ARV) medications, better attitude to health was developed and improved long-term prognosis for many people living with HIV have been witnessed. 3 Also, expansion of ART services and the effectiveness of treatment of HIV/ADIS have resulted in reclassifying HIV as a chronic disease and illness or as an ''episodic disability'' because of periods of wellness and illness embedded in living with an incurable disease. 2, 3 While the new hope from the ARVs is unprecedented global development, the requirement of indefinite adherence to the treatment demands the clients a significant modification of life style and retention in lifelong intensive treatment. 4 Meeting these requirements at times is a huge challenge for patients. Factors related to socioeconomic status, health care systems, therapy itself, and the patient pose hindrance to ARV adherence. 4, 5 Several barriers that prevent the optimal utilization of ART services have been identified by different investigators. These barriers were grossly divided into barriers at population level and barriers at system level. The most frequently reported barriers at the population level include lack of information on the treatment, the perceived high cost of ART, and social stigma associated with HIV/AIDS. Also, social and cultural barriers threaten adherence to ARV medications by creating fear of stigma and social discrimination and the failure of disclosure of their HIV-positive status. ARV users in different settings report stigmatization and discrimination and lack of social support. Disclosing HIV-positive status may jeopardize the job of some of the people living with HIV (PLHIVs). Other may be abandoned or badly treated by their partners or may be socially isolated by community members. This social discrimination causes ARV users to decide to hide their HIV status from colleagues, friends, and others. If the HIV-positive status is not disclosed, patients my compromise their adherence to ARV medications by taking their medicines secretly and irregularly, they may skip their daily doses if privacy is unavailable at a scheduled dosing time or decide to boycott treatment. [6] [7] [8] [9] Health-system level barriers such as long walking distance between home and care providing health facilities, lack of coordination of services within health facilities, and limited involvements of the community in the planning process are hindering factors of good ART adherence in many settings. [3] [4] [5] Out-of-pocket expenses such as user fees for registration and laboratory tests, and cost of long-distance transportation remain important barriers to sustain adherence and medical care. Lack of a means of transportation is also an additional challenge for patient in the remotest parts of rural areas in resource-constrained countries. Missed work-hours during regular clinical follow-up is additional economic burden to PLHIVs in care and treatment and their families. [4] [5] [6] [7] [8] In low-income countries, longer waiting time in ART clinic is a daunting challenge that has contributed to poor adherence to ARV medications and attrition from treatment. 7 Inadequate expansion of ART services, shortage of health workforce particularly ART-trained cadres and dilapidated infrastructure like rooms and laboratory facilities combined with huge HIVpositive population in some resource-limited settings contributed to long waiting time in ART clinics.
Lack or inadequate adherence counseling leads compromises adherence to ARV medications and retention in care and treatment. While the frequency and quality of counseling are core pillars of adherence, the qualification of the counselors (can be nurses, social workers, or lay counselors) and the quality of training on adherence counseling affects the client adherence to ARV medications. 7, 9, 10 Ethiopia is one of the countries where HIV/AIDS epidemic has created huge burden on the health care system and remain to be a threat to lives of people. The adjusted single-point estimate from the 2005 sentinel surveillance and Ethiopian Health and Demographic Survey (EDHS) have shown that the prevalence of adult infection is 2.1% (urban 7.7%, rural 0.9%). In 2006 alone, a total number of 88 997 people died due to HIV/AIDS and the estimated number of death in 2007 was 71 902 AIDS cases. 11, 12 Although ART service in Ethiopia was started early 2004, it had been limited to mostly urban hospitals. In 2006, the Government of Ethiopia decentralized ART service from hospitals to health centers. Consequently, HIV-positive people in all corner of the country have been able to access care and treatment closer to where they live. From 2004 to March 2010, a total of 251, 060 HIV-positive people in Ethiopia are ever started on ART. 13 Like several low-income countries, multiple sociocultural and economical factors limited the rate of ART expansion and the quality of service provision in Ethiopia. Both monetary and factors related to regular follow-up are major reasons for low enrollment in HIV care and treatment and attrition from care and treatment. [14] [15] [16] The aims of this study were to describe the major reasons of patient attrition from treatment at hospital and health center levels in the Oromia region of Ethiopia.
Methods

Study Design and Population
This study, using a qualitative research design, was conducted in March 2009 in the Oromia region, Ethiopia. A projection from the 2007 Ethiopian Population and Household Census shows that the Oromia region has a population of slightly less than 30 million. 17 Oromia region ranks second among all the regions of Ethiopia in number of PLHIVs, with a third of the Ethiopian HIV-positive people living in Oromia. 18 Three hospitals in the Oromia region started providing free ART services in March 2005. Shortage of physicians and availability of few hospitals in the region 19 prompted the transferring of ARV prescribing responsibility from physicians to nurses and ART service was decentralized from hospitals to health centers. Consequently, ART-eligible HIV-positive persons living in the rural areas have got improved access to HIV care and treatment.
The study aimed at exploring barriers to sustained treatment and to follow-up of ART patients at hospital and health center levels. Focus group discussions (FGDs) with ART clients and semistructured interviews with health providers were used. To obtain robust information and understand a range of patients' views of issues that cross cut in HIV care and treatment, a purposive recruitment of participants was done. The author (TTB) and ART focal persons at the respective sites selected the participants.
The participants included in the FGDs were older than 18 years, HIV-positive, and taking ARV medications at the study site. Also, the participants included were those who could give informed consent and those who could communicate well in Afan Oromo, the official and local language of the Oromia region of Ethiopia. The interview questions were first prepared in English and the author translated them into Afan Oromo. The content validity of the original questions and the translations was assessed by the ART expert at Oromia Regional Health Bureau (ORHB).
Eligible ART patients who came for follow up on the day of the visit to the sites were approached by the ART focal persons at the facilities. Three of the participants approached declined to participate. Prior to each FGD and individual interview, the study participants were asked for a verbal informed consent. The aims of the study, its confidentiality, and each individual's right to terminate their participation at any time were clearly explained. Also, as an introduction to each FGD session, an individual interview concerning sociodemographic variables, past history of mental illness, and the time duration that the participant had known his/her HIV status and duration on ART were asked. This was done to reassure the participants about the confidentiality regarding personal information. When sufficient explanation had been given by the researcher, the members of each FGD agreed that the session could be audiorecorded.
All the FGD sessions were led by the author (TTB), who is fluent in Afan Oromo. The author had the ambition to disregard any of his personal experience as a former regional HIV team leader in order to avoid any potential bias from preconceived ideas.
Three FGDs were conducted at Bishoftu, Mojo, and Sebeta sites. The participants discussed their initial reactions to living with HIV, their motivation and desire to start and remain on life-long treatment, and potential reasons for loss to followup. Perceptions and beliefs about ART and experiences of stigma and discrimination were also elicited. The groups brought up the implication of cost of traveling to treatment site and perceived requirement of supplementary diet. Expansion of ART to more health centers was also brought up during the discussion.
All FGDs were conducted at the waiting areas of respective ART clinics. While about 10 minutes were adequate to take individual history in separate places, the FGDs lasted from 45 minutes to 1 hour. Although the ART focal person was involved in participants' recruitment, the qualitative part of the study was not linked to the review of the medical record.
The number of participants in each FGD was 4 or 5. The participants of 2 of the FGDs were all women and 1 group comprised only male participants. A total of 9 (64%) women and 5 (36%) men ranging in age from 26 to 37 years participated in the discussion. Two (14%) participants had finished high school, 7 (50%) went to formal school, and 5 (36%) were illiterate. Twelve (86%) of the FGD participants were unemployed. Only 2 (14%) participants stated that they were formally employed. The health center FGD participants were 9 (coded HC1 to HC9) and the 5 hospital FGD participants were coded HS1 to HS5.
The individual interviews with semistructured questions were then carried out with ART focal persons and they lasted from 50 minutes to 1 hour. After sociodemographic variables were taken, a tape recorder was used with informed consent. From the providers' perspectives, the ART focal persons provided us with more insights into factors for loss to follow up and significance of decentralization of ART to health centers. The participants of the interview included an MD, a health officer, and a nurse. Again, the author went through all open-ended questions in Afan Oromo at respective ART clinics. The 3 health providers included in the semistructured interviews were coded HP1, HP2, and HP3
The tape-recorded focus group sessions and interviews were transcribed verbatim and translated into English. From the transcripts and the field notes taken by the researcher, analytical categories and explanations were generated.
Ethical Considerations
Approval to conduct the study was obtained from local Institutional Ethical Review Committee at the ORHB. Also, permission to conduct the study was obtained from the health facility leadership at each ART site. Before the FGDs and individual interviews were conducted, verbal informed consent was obtained from the participants. The aims of the study, its confidentiality, and individual or group right to withdraw participation at any time was stated clearly. Respondents unanimously agreed that the author could audio-tape each session of the discussions and interviews. Confidentiality was assured that personal information recorded or documented in this study would not be made public.
Data Analysis
After data collection was completed, audio-recorded data were carefully transcribed verbatim by the author. The transcripts and the field notes taken by the author were coded and analytical categories were generated from the data. Nonverbal communication and gestures observed were weighed up to maintain the accuracy of the findings. The methods used during transcribing and coding were adapted from the qualitative data analysis discussed by Pope. 20
Findings
Four major themes emerged from the qualitative analysis of the transcripts of the FGDs with ART patients and semistructured interviews with providers: ARV medications as ''long-term life support,'' free ART as ''expensive,'' regular follow up as ''devotion to a life-long crisis management,'' and expansion of free ART as ''sharing the new hope.'' These major themes were further described below with verbatim quotes. Interestingly, participants' perception of ART was generally positive. Majority of them had strong faith in ARV medications and anticipated a ''brighter future'' with the treatment. Nevertheless, they could not hide their everyday discontent because of the ''incurable illness'' and financial challenges they went through after they began ART.
ARV medications as ''Long-Term Life Support''
The participants of the FGDs described ARV medications as long-term life support. They also noted that ARV medications were highly efficacious and considered them as their lifeline. The majority of the participants also revealed difficulties when coping with their HIV status initially, which were followed by courage and optimism. Furthermore, they underlined the importance of disclosure of the HIV test results as a coping mechanism. The following quote came from a male ART patient at a health center:
My initial reaction to the sad news was horrible. I had tuberculosis and I was tested positive for HIV. I didn't want to start treatment right away. I felt hopeless. You can imagine how it feels. I struggled a lot to hide it. But I finally told my brother. I got relieved and he also encouraged me to start treatment and I did. Now, I am happy that I started it then. (HC3)
The participants had positive attitudes toward ART. They remembered the HIV-related deaths before the expanded access to ART in the country as ''appalling.'' Also, they illustrated their firm belief in treatment and indicated that the side effects of ARV medications were negligible. Nonetheless, they considered ART as ''a long-term life support for incurable illness'':
Everyday, there used to be a funeral ceremony. Nobody tells you that a person died of AIDS. But, you know, AIDS was pruning our community. It was appalling! With treatment, all that has changed. Although AIDS is incurable, the treatment has supported our lives for a long time. The participants also noted that the frequency of AIDS-related illnesses were fewer with ARV medications. In effect, they agreed that they had to adhere to a life-long treatment and follow-up. Some participants took the efficacy of ARV medications for granted and pointed out that their priority evolved from accessing the treatment to finding jobs:
After I started the medicine, I felt strong. Every one of us actually felt that way. Our time in bed was over. Well, we know our lives rest on medicines. Yes, they are part of our lives. But, thanks to the government. They provided us with what we needed. And our need, however, has changed. We need jobs to support ourselves and our families. (HC9)
Interviews with ART focal persons also revealed that initial reactions to positive HIV test results ranged from hopelessness to ideation of revenge. Even worse, some HIV-infected persons were reportedly infecting others intentionally. The providers highlighted that the initial ''crisis'' changed as they were provided with adherence and psychosocial counseling:
Unfortunately most patients were desperate in the beginning. They took it as unfair death sentence. Some were filled with thoughts of revenge. Disclosure to families and our counseling often change their course of actions. They usually start to live positively. (HP2)
The individual interview with ART focal persons also asserted that the functional status of ART clients was changing. They stated that the principal need of the patients transformed from ARV medications to jobs. The following quote taken from ART nurse reflected on patients' remarkable improvement after ART: Some ART clients were initially bed ridden. Even those who were ambulatory were bone and skin. They couldn't come to this facility without support. Now, these people look perfectly well. Their quality of life has improved. As far as they take their medications properly, I hope they will live. (HP3)
The crucial roles of the peer educators in sustaining some patients on treatment were emphasized by the ART focal person at one of the hospitals. He reported that peer educators were trained in adherence counseling and that they continuously transferred knowledge to their fellow ART patients. In other words, the ART patients upheld one another to remain in care and treatment:
It is common that an ART patient abandons his/her hope at certain point in time. More than our adherence counseling, peer advice and support keep them going. Most of them are convinced that only ARV medications are effective against AIDS. This might be more evident in some health facilities than others. There are trained peer educators who are working tirelessly on the issue in our hospital. (HP1)
Free ART as ''Expensive''
Although ART was free at the point of use, the FGD participants underlined that several costs were associated with the treatment. The participants highlighted that only ARV medications and few laboratory investigations were free. Moreover, the majority of the participants implied that expensive cost of transportation and accommodation pulled some patients out of follow-up and treatment. Evidently, some of the participants reported that they struggled to cover their own ART-related expenses:
We come here at least once a month. Others think that ART is free. They don't see costs associated with the treatment. In fact, we found out that ART was rather expensive. We have to pay for laboratory investigations except CD4 count. We have to pay for other medicines. We pay our transportation fees. Some of us have to stay a night or two. Accommodation is expensive. In general, the town is expensive. And some of us are selfemployed. We leave our work for two to three days. These were major reasons for some patients to stop treatment. (HS2) Some participants also added that an ART patient requires more nutritious diets than a ''normal'' person. They stated that they had to change their routine feeding habits to more balanced diets. Meanwhile, the participants tried to justify their view as ARV medications ''were too strong'' to take along with routine diet of Ethiopians, namely, ''injera'' with ''shiro.'' The diet is made of cereals and legumes. Others asserted that ARV medications were completely different from conventional medicines:
We cannot take ARV medications while eating ''injera'' with ''shiro.'' To stand these very strong medicines, presumably you know, we need a balanced diet. We need more proteins and vitamins. These are meat, egg, milk, and fruits. Otherwise, the medicines will affect our body. On the other hand, these are expensive for us. (HC7) The participants expressed concern about ''expensive ART'' due to unrelenting stigma and discrimination in the community. Some participants viewed their own regular follow-up visits to ART clinic as unintended disclosure of their HIV status to several people living in their community. As the participants described, as a result of this and appearance on local media, some have lost their homes. Also, they implied that fear of stigma and discrimination forced some ART patients to stop treatment. Nonetheless, the participants reported no missed appointment or treatment interruption by themselves. A female ART patient at health center described it as follows: I started taking ARV medications and came out on media to talk about the benefits of the medicines. The next day my landlord told me to move out of the house he rented me. No one was sympathetic enough to rent me a house and I had nowhere to go . . . . This is an outright stigma and discrimination against me and fellow people living with HIV/AIDS. This kind of bad treatment discourages us from adhering to treatment. That is one way that our secret is revealed to others. Yet, we value our lives. We never quit. (HS3)
The ART focal persons, however, noted that stigma and discrimination against HIV-positive persons was on the decline. They attributed the reduction of stigma to several awareness creation programs in the community. Examples given were community conversations, care and support programs, and educational activities by faith-based organizations. However, a nurse and HIV-focal person at a health center said that stigma still existed in the community and it posed a challenge to the accelerated expansion of HIV prevention, care, and treatment:
Gradually HIV-related stigma and discrimination are decreasing. This is because of awareness creation activities in the community. There are strong community level activities like community conversation, education by religious organizations and care and support. But, we have still a long way to go. Fear of stigma still affects patient retention in care and treatment. (HP2)
Expansion of Free ART as ''Sharing the New Hope''
The participants expressed their support and enthusiasm for expansion of ART sites. They set universal access to HIV care and treatment as their desire. According to them, bringing ART service closer to the community reduced the cost of treatment. A female ART patient at health center stated her desire as follows:
As treatment was expanded to the health centers closer to us, the cost we bear during regular follow up decreased. Some of us now walk to the health center to pick up our medicines. The community is also now more familiar with the disease and its treatment. Also, our desire is to see all HIV-positive people get this golden opportunity-accessing treatment. We have to share the hope. (HC6) Some participants revealed their personal preference of health centers to hospitals. They described hospitals as congested areas, and they further stated that it was difficult to get adequate attention from health providers at hospitals: I started taking the medicines at hospital. Well, I shouldn't blame the health workers. They couldn't give me sufficient time. Well, there were a bunch of folks at the clinic. They all needed attention. This health center is a different place. There are few ART clients. During each follow up, I have more time with the nurse. I tell her all my problems and receive all the advice . . . . (HC4) The providers added that decentralization of ART from hospitals to health centers enhanced the service uptake and also improved retention of patients in care and treatment. Optimum quality of care and treatment after decentralization was attributed to strong referral linkage between health facilities:
Initially, I had a reservation that ART could not be provided beyond hospitals. As the expansion went on, some health centers started initiation of ART effectively. I was convinced that ART could be given at health center without compromising the quality of the service. Referral of blood samples for CD4 count determination is going perfect. And we have already seen that health centers are doing a good job. (HP1)
Regular Follow-Up as ''Devotion to Life-Long Crisis Management''
When elicited to provide their opinions on loss to follow-up and retention on treatment, the participants discussed the importance of adherence counseling. They further incriminated stigma, financial challenges, and lack of community support for high rate of loss to follow-up. Also, they related loss to follow-up to strong belief in holy water and witch doctors among a large segment of the society. A quote from a female ART patient at a hospital reads as follows:
People hated me. I also hated myself. I wish I could buy death. To live, I have to stand the hatred against me . . . . You know, it is a life-long crisis. I have to devote myself to manage it. At times, some resort to holy water or witch doctors. Well, I will never give up. I have to live for my children. (HS3) Interviews probed into more barriers to retention in care and on treatment showed that ART patients expected more support from the government to sustain their regular follow-up. The participants suggested that the government could cover all the expenses of ART like medicines for opportunistic infections (OIs) and laboratory investigations. Also, they implied that the government could hand out food with appropriate nutritional values:
We know the government is highly concerned about the health of its citizens. That is why we are getting free ART. However, the support should not be partial. They could make all the medicines free for HIV-positive persons. All the laboratory tests should be free. These are part of the treatment. I would say that most of us need supplementary food. These are important for us to carry on. (HC8)
The participants mentioned lifestyles-related factors' role in treatment interruption. According to the participants, some patients preferred stopping ART to quitting khat chewing or alcohol consumption:
The health workers tell us not to chew khat or consume alcohol. Some patients do not want to stop taking them. They are addicted to them and they would rather stop the treatment.
ART focal persons also added that financial constraints, perceived requirement of additional diet, and resorting to holy water were the commonest reasons for loss to follow-up. They said that most of the patients who stopped treatment resorted to holy water:
The majority of patients who defaulted ART go to holy water. Most of them believed that holy water was a viable option to ARV medications. Others simply believed that they required special diet to take ARV medications. The widespread belief was that ARV medications would be effective only with ''good'' nutrition. And some patients struggle with crippling financial problems. (HP1)
Discussion
The FGDs with the ART patients aimed at revealing perceptions of the service by the clients and describing factors impeding retention in HIV care and treatment. Although there were self-defeating reactions to the news of being infected with HIV and ideation of revenge initially, the majority of the participants had a strong faith in ARV medications. Indicating the requirement of the life-long follow-up and incurability of the illness, they dubbed the treatment as ''long-term life support.'' Also, the participants underlined the importance of disclosure of the HIV test results and the treatment as coping mechanisms and ways of obtaining support from family and the wider society. Although the characteristics of the study population were different, the positive association between disclosure and social support concurs with the study conducted within stigmatized populations in the United States. 21 The majority of the participants reported fewer bouts of opportunistic infections and negligible side effects of ARV medications. As they took the effectiveness of the ART for granted, some participants revealed that their eclectic need changed from treatment to securing jobs and supporting their families. The individual interview with the providers also confirmed a remarkable improvement in functional status of the ART patients. All the FGD participants agreed that adhering to care and treatment was important for sustainable efficacy of ARV medications.
The participants of the FGDs revealed that several costs were associated with the free ART. The majority of them pointed out that they struggled to cover costs of non-ARV medicines and laboratory investigations. It is likely that the shortage of non-ARV medicines and supplies at public health facilities increased the expenses. Likewise, transportation and accommodation expenses were listed as barriers to the initiation of ART and to the retention in the program. Cost of transportation to remote hospitals and accommodation during follow-up were also cited as reasons for loss to follow up, which concurred with the result reported from a similar program in Malawi. 22 Perceived requirement of extra food and a strong-held view of ARV medications as nonconventional medicines further forced some patients to drop out of follow-up. These were also raised as concerns among HIV-infected focus groups from Tanzania. 23 Inexorable stigma and discrimination by the community was also mentioned as a barrier to accessing ART and reasons for treatment interruptions. Nonetheless, the participants reported no missed appointment by themselves. On the other hand, the ART focal persons noted that stigma and discrimination against HIV-positive persons were declining, which they attributed to large-scale community conversations, care and support programs, and educational activities by faithbased platforms. However, they cautioned that stigma still remained a challenge for the accelerated expansion of HIV prevention, care, and treatment.
Strong support and profound enthusiasm for expansion of ART sites was noticed among the participants. Some participants even highlighted that bringing ART service closer to the community reduced the costs of treatment and benefitted scores of HIV-positive persons. Moreover, some participants said that they preferred health centers to hospitals for follow up. According to them, hospitals were congested areas where attention they got was unsatisfactory. This opinion substantiated a quantitative study in a similar setting that reported better outcomes of ART at health centers than hospitals. 24 The providers asserted that the decentralization of ART to health centers enhanced the service uptake and also improved retention of patients on treatment.
The participants mentioned lack of community support as a barrier to retention in ART program. A study conducted in Malawi also indicated that strong community support was associated with better outcomes of ART. 25 Lifestyles like khat chewing and alcohol consumption were also stated as factors interfering with the retention on ART. The participants acknowledged that few patients preferred quitting ART to cutting their alcohol consumption. Furthermore, the participants pointed out that many patients took vacation from ARV medications for some time or totally resorted to a holy water as an alternative to ART, which is in agreement with another study from Ethiopia, 11 and a few others went to witch doctors. The majority of the participants sought more support from the government, the health facility, and from the community as a new way forward for better outcomes. Nonetheless, both the ART clients and health providers singled out ART as an important milestone in the fight against HIV, underscored the importance of treatment adherence and regular follow-up, and concluded that decentralization of the service to health centers boosted retention on treatment. Expansion of the service to more health centers, establishing patient support groups and more involvement of PLHIVs in peer counseling, may have imperative impact on patient retention in ART program.
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